296 related articles for article (PubMed ID: 28224765)
1. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
[TBL] [Abstract][Full Text] [Related]
2. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Wang Y; Fang M; Sun X; Sun J
Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
6. Telomere shortening and chromosomal instability in myelodysplastic syndromes.
Lange K; Holm L; Vang Nielsen K; Hahn A; Hofmann W; Kreipe H; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2010 Mar; 49(3):260-9. PubMed ID: 19998444
[TBL] [Abstract][Full Text] [Related]
7. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
[TBL] [Abstract][Full Text] [Related]
8. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
10. Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome.
Poloni A; Serrani F; Berardinelli E; Maurizi G; Mariani M; Costantini B; Trappolini S; Mancini S; Olivieri A; Leoni P
Leuk Res; 2013 Nov; 37(11):1538-44. PubMed ID: 24095110
[TBL] [Abstract][Full Text] [Related]
11. Telomere length is an independent prognostic marker in MDS but not in de novo AML.
Williams J; Heppel NH; Britt-Compton B; Grimstead JW; Jones RE; Tauro S; Bowen DT; Knapper S; Groves M; Hills RK; Pepper C; Baird DM; Fegan C
Br J Haematol; 2017 Jul; 178(2):240-249. PubMed ID: 28486748
[TBL] [Abstract][Full Text] [Related]
12. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Wu KD; Orme LM; Shaughnessy J; Jacobson J; Barlogie B; Moore MA
Blood; 2003 Jun; 101(12):4982-9. PubMed ID: 12609839
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in myelodysplastic syndrome.
Fu C; Chen Z
Chin Med J (Engl); 2002 Oct; 115(10):1475-8. PubMed ID: 12490090
[TBL] [Abstract][Full Text] [Related]
14. Telomeres and telomerase in normal and leukemic hematopoietic cells.
Engelhardt M; Wäsch R; Guo Y
Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
Rigolin GM; Bigoni R; Milani R; Cavazzini F; Roberti MG; Bardi A; Agostini P; Della Porta M; Tieghi A; Piva N; Cuneo A; Castoldi G
Leukemia; 2001 Dec; 15(12):1841-7. PubMed ID: 11753603
[TBL] [Abstract][Full Text] [Related]
16. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of telomere length testing in a hospital-based setting.
Alder JK; Hanumanthu VS; Strong MA; DeZern AE; Stanley SE; Takemoto CM; Danilova L; Applegate CD; Bolton SG; Mohr DW; Brodsky RA; Casella JF; Greider CW; Jackson JB; Armanios M
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2358-E2365. PubMed ID: 29463756
[TBL] [Abstract][Full Text] [Related]
18. No telomere shortening in marrow stroma from patients with MDS.
Marcondes AM; Bair S; Rabinovitch PS; Gooley T; Deeg HJ; Risques R
Ann Hematol; 2009 Jul; 88(7):623-8. PubMed ID: 19050887
[TBL] [Abstract][Full Text] [Related]
19. The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.
Chan D; Martin-Ruiz C; Saretzki G; Neely D; Qiu W; Kunadian V
PLoS One; 2020; 15(1):e0227616. PubMed ID: 31923255
[TBL] [Abstract][Full Text] [Related]
20. Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.
Ketterling RP; Wyatt WA; VanWier SA; Law M; Hodnefield JM; Hanson CA; Dewald GW
Leuk Res; 2002 Mar; 26(3):235-40. PubMed ID: 11792411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]